StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Relmada Therapeutics Inc (RLMD) PT Raised to $19 at Mizuho
March 20, 2026 6:35 AM
(Updated - March 20, 2026 6:37 AM EDT)
Mizuho analyst Uy Ear raised the price target on Relmada Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change